In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Taking Stock of Public Investor Interest in Device Companies

Executive Summary

Intuitive Surgical is the closest thing the health care industry has to Google Inc. With shares trading at or around $300 at publishing time, the robotic surgery pioneer clearly leads the field in a review of five-year and one-year stock valuations of publicly-traded medical device companies conducted by IN VIVO. According to this survey, over the past five years, public investors have shown a strong level of support for the stock of companies with a laser-like focus on a single market area.
Advertisement

Related Content

What Happens After the Device IPO?
Divide Growing Between Strong, Weak Medical Device IPO Companies
Divide Growing Between Strong, Weak Medical Device IPO Companies
Medical Device and In Vitro Diagnostics Deal Statistics Quarterly, Q4 2007
Medical Device and In Vitro Diagnostics Deal Statistics Quarterly, Q4 2007
Cytyc Together with Hologic: There's a Certain Logic
Intuitive Surgical: Making Robotics Real
Intuitive Surgical: Making Robotics Real

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003073

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel